Xgeva Sales Data

Rank 91 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Xgeva U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 91 (1) 3.24% 3.08%
Q3 2013 90 (4) 1.10% 2.36%
Q2 2013 86 (8) 3.97% 4.10%
Q1 2013 94 (2) 4.84% 5.17%
Q4 2012 96 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
June 13, 2013Xgeva Approved for Rare, Non-Malignant Tumor
February 9, 2012Health Highlights: Feb. 9, 2012
Hide
(web5)